it has little to do with what medicine a person takes
Study outcomes According to the treatment-regimen estimand, adults receiving orforglipron 12 mg had a 1.71 percentage point decline in HbA1c, and those receiving orforglipron 36 mg had a 1.91 percentage point drop in HbA1c at 1 year compared with a 1.23 percentage point reduction with semaglutide 7 mg and a 1.47 percentage point decrease with semaglutide 14 mg
By month two and onward, the full therapeutic effect of semaglutide becomes clear
Fatigue, nausea, and abdominal discomfort appear in both conditions
Most experienced researchers prefer the Mod GRF 1-29 approach for its cleaner, more controllable profile
While these compounds can support body composition improvements, they work through entirely different mechanisms than AOD-9604